Anti-polyethyleneglycol antibody response to PEGylated substances

62Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

Abstract

In contrast to the general assumption that polyethyleneglycol (PEG)-conjugated substances lack immunogenicity and antigenic, it has been reported that they can elicit antibodies against PEG (mainly anti-PEG immunoglobulin M (IgM)). In patients, the presence of anti-PEG antibodies may limit therapeutic efficacy of PEGylated substances as a consequence of inducing rapid clearance of and neutralizing biological activity of the substances. Here, we introduce specific examples of PEGylated substances including several PEGylated proteins and PEGylated particles (PEGylated nanocarriers) which induce anti-PEG antibody responses. Finally, we emphasize that the immunogenicity of PEGylated substances should be tested in the development stage and that the titer of anti-PEG antibodies in patients should be pre-screened and monitored prior to and throughout a course of treatment with a PEGylated substance. © 2013 The Pharmaceutical Society of Japan.

References Powered by Scopus

Effect of pegylation on pharmaceuticals

3075Citations
N/AReaders
Get full text

PEGylation, successful approach to drug delivery

2092Citations
N/AReaders
Get full text

Chemistry for peptide and protein PEGylation

1408Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers

1035Citations
N/AReaders
Get full text

Protein interactions with polymer coatings and biomaterials

658Citations
N/AReaders
Get full text

Drug Delivery Approaches in Addressing Clinical Pharmacology-Related Issues: Opportunities and Challenges

438Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Ishida, T., & Kiwada, H. (2013). Anti-polyethyleneglycol antibody response to PEGylated substances. Biological and Pharmaceutical Bulletin, 36(6), 889–891. https://doi.org/10.1248/bpb.b13-00107

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 15

60%

Researcher 8

32%

Professor / Associate Prof. 1

4%

Lecturer / Post doc 1

4%

Readers' Discipline

Tooltip

Chemistry 6

33%

Medicine and Dentistry 5

28%

Biochemistry, Genetics and Molecular Bi... 4

22%

Pharmacology, Toxicology and Pharmaceut... 3

17%

Save time finding and organizing research with Mendeley

Sign up for free